Carman Alenson
Comptroller/Controller/Auditor at PRIME MEDICINE, INC.
Net worth: - $ as of 2024-03-30
Profile
Carman Alenson is currently working as the Principal Accounting Officer at Prime Medicine, Inc. Ms. Alenson previously worked as the Executive Director-Accounting & Controller at AMAG Pharmaceuticals, Inc. from 2015 to 2016 and as the CAO, Vice President-Accounting, Treasury & Tax at Agios Pharmaceuticals, Inc. from 2016 to 2021.
Ms. Alenson obtained an undergraduate degree and an MBA from Boston University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRIME MEDICINE, INC.
-.--% | 2024-02-20 | 0 ( -.--% ) | - $ | 2024-03-30 |
Carman Alenson active positions
| Companies | Position | Start |
|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 2021-07-31 |
Former positions of Carman Alenson
| Companies | Position | End |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2021-07-29 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2016-09-30 |
Training of Carman Alenson
| Boston University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Carman Alenson